On July 7, 2025, Beijing DHH Law Firm (hereinafter referred to as &quot;DHH&quot;) and Germany-based Wuethoff &amp; Wuesthoff Intellectual Property Law Firm officially signed a strategic cooperation agreement in Beijing, and jointly organized the &quot;Sino-European Pharmaceutical Intellectual Property Protection and Innovation Seminar&rdquo;. This marks the official commencement of deep collaboration between the two legal service firms in the field of pharmaceutical intellectual property. China and Germany maintain close ties in areas such as trade, investment and technological cooperation, the demand for cross-border legal services in the pharmaceutical industry has surged. Through this cooperation, the two law firms will establish a Sino-German legal practice exchange platform to assist Chinese pharmaceutical enterprises in successfully entering the European market while addressing European intellectual property compliance risks. 　　As an important starting point of strategic cooperation, the two law firms jointly organized the &quot;Seminar on Intellectual Property Strategy for Chinese Pharmaceutical Companies Entering Europe and Latest Developments of the Unified Patent Court (UPC)&quot; on July 8. Dr. Thomas Sonnenhauser, Dr. Jiang Bo, and Senior Equity Partner Huang Zhengyu delivered speeches at the seminar, while the seminar was co-hosted by Equity Partner Wang Wenjun and Senior Consultant Xia Ying. 　　The successful holding of this strategic cooperation signing ceremony and thematic seminar has not only deepened the professional collaboration between the two leading law firms from China and Germany but also provided professional support for Chinese pharmaceutical enterprises to overcome challenges related to European intellectual property compliance and enhance their international competitiveness. Looking ahead, Beijing DHH Law Firm will continue to deepen the strategic synergy with Wuethoff &amp; Wuesthoff, jointly safeguarding the overseas expansion of enterprises.

DHH and Wuethoff & Wuesthoff (Munich,Germany) Enter into Strategic Cooperation Partnership and Successfully  Co-Host Seminar on Intellectual Property Strategy for Chinese Pharmaceutical Enterprises Entering Europe 

<div style="text-align: justify;">On April 16th, 2025, under the guidance of&nbsp;Beijing (Haidian) Municipal Administration for Market Regulation the &quot;Prevention and Response to U.S. Section 337 Investigations&quot; seminar was successfully held. The event was co-hosted by Beijing DHH Law Firm and the Capital Intellectual Property Services Association. More than 50 representatives from enterprises, law firms, and intellectual property agencies attended the seminar to discuss strategies for risk prevention and responses to U.S. Section 337 investigations. &nbsp;</div><img alt="" src="https://deheheng.oss-cn-beijing.aliyuncs.com/file/202504/b0beac7e14ccc8561e6c310c07dbe89d.png" style="width: 600px; height: 340px;" /> The seminar was chaired by WANG Wenjun, Director of DHH&#39;s&nbsp;Intellectual Property&nbsp;Business Center. Executive Director LU&nbsp;Yang, Lawyers WEI&nbsp;Guihong and GE Jia, and Patent Agent, Lawyer LI&nbsp;Ying also participated in the event and delivered speeches. <img alt="" src="https://deheheng.oss-cn-beijing.aliyuncs.com/file/202504/f6fe94f3a07f6b658fb10c6e1a1ef307.png" style="width: 600px; height: 395px;" />
<div style="text-align: justify;">During the meeting, attendees actively asked questions and engaged in in-depth discussions with the speakers. Chinese companies that had successfully defended themselves in Section 337 investigations shared their experiences. As part of the &quot;International Intellectual Property Day&quot; series of events, the seminar aimed to strengthen intellectual property protection awareness among Chinese enterprises, promote compliance and sustainable development, and enhance their competitiveness in the global market.</div>